EUCTR2016-002983-16-ES进行中（未招募）1 期
PILOT STUDY TO COMPARE THE EFFICACY OF EVOLOCUMAB VS LDL-APHERESIS IN PATIENTS WITH HYPERCHOLESTEROLEMIA
SERVICIO DE NEFROLOGIA0 个研究点开始时间: 2016年11月18日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •PATIENTS OLDER THAN 18
- •FAMILIAR HYPERCHOLESTEROLEMIA WITH LDL-CHOLESTEROL GREATER THAN 100 MG/DL AND TREATMENT WITH HIGHER STATIN DOSAGE, AND PREVIOUS CARDIOVASCULAR EVENTS
- •PATIENTS WITH LDL-APHERESIS TREATMENT
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 10
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •EVOLOCUMAB CONTRAINDICATIONS
- •HOSPITALIZATION IN THREE PREVIOUS MONTHS
- •CARDIOVASCULAR EVENTS IN THREE PREVIOUS MONTHS
研究者
相似试验
进行中（未招募）
1 期
Efficacy and safety of Evoluocumab added Standard of Care in high cardiovascular risk haemodialized statin intolerant patients with hypercholesterolemia.High cardiovascular risk haemodialized statin intolerant patients with hypercholesterolemia.MedDRA version: 20.0Level: HLGTClassification code 10013317Term: Lipid metabolism disordersSystem Organ Class: 10027433 - Metabolism and nutrition disordersMedDRA version: 20.0Level: SOCClassification code 10007541Term: Cardiac disordersSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 20.0Level: SOCClassification code 10047065Term: Vascular disordersSystem Organ Class: 10047065 - Vascular disordersEUCTR2019-001491-11-ITIRCCS SAN RAFFAELE PISANA GESTITO DA SAN RAFFAELE ROMA SR50
已完成
3 期
evofloxacin effect on eradication of Helicobacter Pylori infectioHelicobacter Pylori infection.Helicobacter pyloriIRCT2015081818124N2Qazvin University of Medical Sciences120
进行中（未招募）
1 期
A trial to compare the effects of nebivolol versus atenolol on various cardiovascular measurements including insulin sensitivity - Nebivolol trialHypertensionEUCTR2005-001214-40-GBImperial College London50
已完成
不适用
?Effect of empowerment program on the perception of risk and health dimensions in patients with coronary heart diseasecoronary artery disease.Atherosclerotic heart diseaseIRCT201607254443N22Vice chancellor for research of Tehran university of medical sciences84
进行中（未招募）
Unknown
Management of gum loss using patients own tissue and animal derived material coated with patient blood productCTRI/2023/08/056045Polimera Sanathana